Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GeoVax Labs (GOVX) Other Accumulated Expenses (2016 - 2021)

GeoVax Labs (GOVX) has disclosed Other Accumulated Expenses for 7 consecutive years, with $35000.0 as the latest value for Q3 2021.

  • On a quarterly basis, Other Accumulated Expenses rose 25.8% to $35000.0 in Q3 2021 year-over-year; TTM through Sep 2021 was $35000.0, a 25.8% increase, with the full-year FY2020 number at $79585.0, down 32.75% from a year prior.
  • Other Accumulated Expenses was $35000.0 for Q3 2021 at GeoVax Labs, down from $69342.0 in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $125700.0 in Q3 2019 to a low of $15000.0 in Q1 2017.
  • A 5-year average of $48506.5 and a median of $35000.0 in 2021 define the central range for Other Accumulated Expenses.
  • Peak YoY movement for Other Accumulated Expenses: skyrocketed 544.09% in 2019, then plummeted 77.87% in 2020.
  • GeoVax Labs' Other Accumulated Expenses stood at $18476.0 in 2017, then fell by 0.56% to $18373.0 in 2018, then surged by 544.09% to $118338.0 in 2019, then tumbled by 32.75% to $79585.0 in 2020, then plummeted by 56.02% to $35000.0 in 2021.
  • Per Business Quant, the three most recent readings for GOVX's Other Accumulated Expenses are $35000.0 (Q3 2021), $69342.0 (Q2 2021), and $36623.0 (Q1 2021).